financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Buy Opinion On Shares Of Antero Resources Corporation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Buy Opinion On Shares Of Antero Resources Corporation
May 7, 2026 12:41 PM

03:30 PM EDT, 05/07/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Our 12-month target remains $48, a 6x multiple of enterprise value to our 2027 EBITDA estimate, in line with AR's historical forward average. We raise our 2026 EPS estimate by $1.11 to $4.37 and our 2027 EPS estimate by $0.76 to $4.90. We see AR as a leading provider of relatively low-cost natural gas, as well as a healthy degree of NGL exposure. Management is 45% hedged in 2026 in the $3.90/MMBtu range, but that hedge protection drops to about the 30% range for 2027. Following the pending Ohio Utica divestiture, and the now-completed HG deal, AR's exposure to the Marcellus only rises. We see the Marcellus as a relatively lower-cost gas play. AR ended 2025 with a net debt-to-EBITDA ratio of just 2.1x, down from 4.9x at the end of 2024, and yielding considerably improved financial flexibility in our view. We estimate that shares are trading at a sizable discount to AR's historical forward average, despite our view that earnings power should improve to nearly 2022-era levels.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Netflix, Inc.
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Netflix, Inc.
May 24, 2024
12:20 PM EDT, 05/24/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target to $725 from $640 on a forward TEV/EBITDA of 26.3x our 2025 EBITDA estimate at $28.14/share, a premium to the peer average at 23.0x and below...
Research Alert: CFRA Maintains Hold Opinion On Booz Allen Hamilton Holding Corporation
Research Alert: CFRA Maintains Hold Opinion On Booz Allen Hamilton Holding Corporation
May 24, 2024
01:20 PM EDT, 05/24/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price to $165 from $150, on a P/E of 25.1x our FY 2026 (Mar.) EPS forecast, a premium to both BAH's three-year historical average and...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Guardant Health, Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Guardant Health, Inc.
May 24, 2024
11:55 AM EDT, 05/24/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price by $3 to $28, reflecting a 3.5x multiple of our 2025 revenue estimate, a discount to GH's historical average due to a long horizon...
Research Alert: CFRA Keeps Buy Opinion On Adss Of Pdd Holdings Inc.
Research Alert: CFRA Keeps Buy Opinion On Adss Of Pdd Holdings Inc.
May 24, 2024
01:45 PM EDT, 05/24/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target price to USD200 from USD155, 13x our 2024 EV/EBITDA (peer median: 11x), on a projected ROE of 51% in 2024 (peer median: 20%). Q1 2024 EPADS...
Copyright 2023-2026 - www.financetom.com All Rights Reserved